Navigation Links
Norovirus, AIDS vaccine and Hepatitis Virus

Norovirus Prevalent in Those Suffering from Traveler's Diarrhea

Norovirus may be the most common cause of travelers' diarrhea for United States citizens returning from Mexico and Guatamala say researchers from the U.S., Guatemala, Mexico and Sweden. Their findings appear in the March 2005 issue of the Journal of Clinical Microbiology.

It is estimated that 20 to 50 percent of the people traveling to tropical areas of the world will experience traveler's diarrhea (TD). TD, defined as three or more loose stool movements in a 24-hour period, frequently results from exposure to bacterial or viral pathogens. Noroviruses (NoV's) are considered to be one of the leading causes of nonbacterial gastro-related illnesses resulting in over 23 million cases annually.

In the study stool samples were collected from 34 patients with traveler's diarrhea and tested for the presence of norovirus. The virus was detected in 65 percent of the samples tested, with time spent at travel destinations playing an important role in determining infection frequency.

"This study is the first of its kind to indicate that NoVs may be a major cause of illness among United States travelers who experience TD during extended stays in developing countries," say the researchers. The high frequency of NoV infection among TD cases examined in this study suggests that further investigations concerning the role of these viruses in TD are warranted."

(A.R. Chapin, C.M. Carpenter, W.C. Dudley, L.C. Gibson, R. Pratdesaba, O. Torres, D. Sanchez, J. Belkind-Gerson, I. Nyquist, A. Karnell, B. Gustafsson, J.L. Halpern, A.L. Bourgeois, K.J. Schwab. 2005. Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea. Journal of Clinical Microbiology, 43. 3: 1112-1117.)

DNA Vaccine Protects Against AIDS, Not HIV

While a new DNA vaccine may not be able to prevent HIV infection, it could protect against progres
'"/>

Source:American Society for Microbiology


Page: 1 2 3

Related biology news :

1. Research advances quest for HIV-1 vaccine
2. A much-needed shot in the arm for HIV vaccine development
3. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
4. Gene vaccine for Alzheimers disease shows promising results
5. Influenza vaccine uses insect cells to speed development
6. HIV vaccine trial breaks ground for future research
7. Live vaccines more effective against horse herpes virus
8. NIAID begins clinical trial of West Nile virus vaccine
9. Designing vaccines by computer
10. Wake Forest scientists find new combination vaccine effective against plague
11. New vaccine means bye-bye to bacteria in the lung

Post Your Comments:
(Date:11/20/2009)...ess an ingenious mechanism for preventing oxygen f...is the new finding of a team of biologists that in...rch institute in Flanders, Belgium, connected to t... this discovery by modifying the DNA of the intest...s model organism, they have uncovered the existenc...
(Date:11/20/2009)...s report that a class of heart medications called ...ct on the heart, depending on their molecular acti... Circulation Research , found that beta-blockers t...he heart muscle offer the most benefit to cardiac ...ceptors can actually undermine the structure and f...
(Date:11/19/2009)...s of the world. It is widely used for human consum...lso is considered an exemplar plant species for st...ome architecture. The authors of the research pres...scription of the B73 maize genome to probe some of...nt biology. The ten papers consider maize centrome...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Carvedilol shown to have unique characteristics among beta blockers 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4The End of the Bio Identical Hormone Debate 56782 1The End of the Bio Identical Hormone Debate 56782 2LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL 28TM 29 Technology 56777 1LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL 28TM 29 Technology 56777 2LifeNet Health and Childrens Mercy Hospital Announce First Implant With MatrACELL 28TM 29 Technology 56777 3Reportlinker Adds World Botulinum Toxin Market Report 56773 1Reportlinker Adds World Botulinum Toxin Market Report 56773 2Reportlinker Adds World Botulinum Toxin Market Report 56773 3Reportlinker Adds World Botulinum Toxin Market Report 56773 4Reportlinker Adds World Botulinum Toxin Market Report 56773 5Reportlinker Adds World Botulinum Toxin Market Report 56773 6Reportlinker Adds World Botulinum Toxin Market Report 56773 7Reportlinker Adds World Botulinum Toxin Market Report 56773 8Reportlinker Adds World Botulinum Toxin Market Report 56773 9Reportlinker Adds World Botulinum Toxin Market Report 56773 10Reportlinker Adds World Botulinum Toxin Market Report 56773 11Reportlinker Adds World Botulinum Toxin Market Report 56773 12
... issue of G&D , Dr. Fred H. Gage (The Salk Instit...a role for the Hippo signaling pathway in the regu...ng new factors and potential therapeutic targets ...orders and neurological tumor formation. , Their...t on 11/17 at http://genesdev.org . , Establishi...
...struction of new coal-fired power plants in the Un..., partly due to the high cost of the requirement ...issions of carbon dioxide, an important greenhouse... step that could get construction moving again, al...shortages using our most-abundant, least-expensive...
...) A new study by researchers at UC Davis Medical ... of some epilepsy patients may be a result of thei...g seizures. , "Significant drops in blood oxygen ... with partial seizures," said study senior author ...Medical Center and director of the UC Davis Compre...
Other Biology News:New molecular insight into vertebrate brain development 2MIT: A quicker, easier way to make coal cleaner 2MIT: A quicker, easier way to make coal cleaner 3Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 2Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 3
(Date:11/20/2009)... , SEATTLE, Nov. 20 D...ed that the U.S. Food and Drug Administration (FDA...y,s amended Biologics License Application (BLA) fo...onse. The FDA has assigned a Prescription Drug Us...ime it will respond to Dendreon,s amended BLA. De...
(Date:11/20/2009)... METTLER TOLEDO recently announ... Process Optimization Using At-Line Particle Chara...2, 2009. In this webinar, the application of in s...ap the design space and optimize a series of rolle...w rates, and roller compaction forces. , ...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...led for November 6, 2008 at 10:00 a.m. EST, EAST ...Inc. (Nasdaq: SVNT ) today reported financial res... 30, 2008. The net loss for the,third quarter of 2...ed,share on total revenues of $0.5 million, compar...asic and diluted share on total revenues of $2.6,m...
...5 Environmental Power,Corporation (Nasdaq: EPG )...ay announced that its wholly owned subsidiary, Mic...agreement with Organix, Inc., of Walla,Walla, Wash... using solids,recovered from selected Microgy anae...ting alliance," said Rich Kessel, President and,Ch...
...swire-FirstCall/ - Dr. Brad Thompson, President,an...SX:ONC, NASDAQ:ONCY),will host a conference call a...a.m. MT (1:00 p.m. ET) to update investors on clin...patients with bone and soft tissue sarcomas,metast...presented November,6, 2008 at the Chemotherapy Fou...
Other Biology Technology:Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 10Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products 2Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products 3Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products 4Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call 2
UltraClean GelSpin Kit from Mo Bio Laboratories, Inc.
DNA Fragment 2X Precipitation Solution from EPICENTRE Biotechnologies
DTT, 25g from BioPioneer
AgarPlaque Plus Agarose from BD Biosciences Pharmingen
Biology Products: